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Abstract
Background: Many countries are facing overlapping epidemics of tuberculosis (TB) and diabetes mellitus (DM).
Diabetes increases the overall risk of developing Tuberculosis (TB) and contributes to adverse treatment outcomes.
Active screening for both diseases can reduce TB transmission and prevent the development of complications of
DM. We investigated bi-directional TB-DM screening in Karachi, Pakistan, a country that ranks fifth among high TB
burden countries, and has the seventh highest country burden for DM.
Methods: Between February to November 2014, community-based screeners identified presumptive TB and DM
through verbal screening at private health clinics. Individuals with presumptive TB were referred for a chest X-ray
and Xpert MTB/RIF. Presumptive DM cases had random blood glucose (RBS) tested. All individuals with bacteriologically
positive TB were referred for diabetes testing (RBS). All pre-diabetics and diabetics were referred for a chest X-ray and
Xpert MTB/RIF test. The primary outcomes of this study were uptake of TB and DM testing.
Results: A total of 450,385 individuals were screened, of whom 18,109 had presumptive DM and 90,137 had presumptive
TB. 14,550 of these individuals were presumptive for both DM and TB. The uptake of DM testing among those
with presumptive diabetes was 26.1% while the uptake of TB testing among presumptive TB cases was 5.9%.
Despite efforts to promote bi-directional screening of TB and DM, the uptake of TB testing among pre-diabetes
and diabetes cases was only 4.7%, while the uptake of DM testing among MTB positive cases was 21.8%.
Conclusion: While a high yield for TB was identified among pre-diabetics and diabetics along with a high yield
of DM among individuals diagnosed with TB, there was a low uptake of TB testing amongst presumptive TB patients
who were recorded as pre-diabetic or diabetic. Bi-directional screening for TB and DM which includes the integration
of TB diagnostics, DM screening and TB-DM treatment within existing health care programs will need to address the
operational challenges identified before implementing this as a strategy in public health programs.
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Background
Nearly one third of the world’s population is infected with
Mycobacterium tuberculosis (Mtb) [1]. A growing body of
literature has established the association between tuberculosis (TB) and diabetes mellitus (DM) in various settings
[2]. DM increases the overall risk of developing TB and
contributes to adverse TB treatment outcomes such as delayed sputum conversion, treatment failure and relapse
and death [2]. The global burden of diabetes is on the rise
with the total number of people living with DM estimated
to reach 438 million by 2030 [3]. The convergence of
these two epidemics poses a significant challenge for
health systems in low and middle-income countries. Studies in India and China found significant evidence for comorbidity at various health care levels including tertiary
care facilities and primary healthcare clinics [4, 5]. These
studies led to important policy formulations that have
mandated screening for DM among all TB patients and
documentation of DM indicators within registries of the
TB control program in these countries.
Screening, early-case detection and prompt treatment initiation is of relevance for both diseases. In 2009, the World
Health Organization (WHO) and the International Union
Against Tuberculosis and Lung Disease (IUATLD) recommended bi-directional TB-DM screening and integrated
management for both diseases in high burden countries [6].
However, in low and middle-income countries, health
systems are often weak and highly fragmented, including
large and often poorly regulated private-sectors, and are
not equipped to respond effectively to the dual burden of
communicable and non-communicable diseases [7].
Pakistan is currently ranked fifth among high TB burden
countries [1]. Nearly half of all cases remain undiagnosed
and improving case-detection is an important target for
the National TB Control Program (NTP) [1]. Pakistan also
faces a rising burden of non-communicable diseases
(NCDs), particularly Type II DM. It has the seventh highest country-burden for DM with an estimated prevalence
of 6.8% in the adult population [8, 9]. Similar to TB patients, diabetics are frequently under-diagnosed and an estimated 3.5 million adults in Pakistan are thought to be
living with undiagnosed DM [9]. In Pakistan, TB control
activities are under the purview of the National Tuberculosis Program (NTP), but routine screening for NCDs including DM is not currently recommended. Interventions
also need to consider the private-sector that provides
healthcare services to nearly three-quarters of all patients
in the country [10].
In recent years, novel case-finding approaches for TB in
the private-sector have been developed to enhance
case-notifications through community-based screening,
cash-incentives for referrals and linking case-notifications
to the NTP disease surveillance system [11, 12]. Similar
public-private models with a focus on integrated care can
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lower costs and improve health outcomes by shifting
diseases-specific interventions to holistic, patient-centric
approaches [13]. We investigated the feasibility of a bidirectional TB and DM screening program in the private
health sector in Karachi, Pakistan as part of an enhanced
case-finding intervention for TB through a social business
approach (described below). The initiative builds upon
previous interventions carried out in the area that were
limited to targeting community-based screening for TB.

Methods
Study design and setting

A cross-sectional study of a bi-directional TB-DM screening program was conducted within a larger study investigating enhanced case-finding intervention for TB in the towns
of Korangi, Landhi, Orangi, North Karachi and Nazimabad
in Karachi, Pakistan, between February to November 2014.
Community health workers (CHW) screened patients
attending 80 general primary care, health provider clinics
for TB and DM. The screening was based on a convenience
consecutive sample. These clinics were primarily privatelyowned facilities of individual physicians and a small number of physician private group-practices, serving 50 or more
patients on average per day.
Screening and testing procedures

CHWs were trained on TB screening and treatment according to NTP guidelines, and on DM screening according to the International Diabetes Federation (IDF) [14].
CHWs were subsequently assigned to private health providers’ clinics where they verbally screened attendees for
presumptive TB and DM. CHWs and health care providers
were incentivized for referrals and case-detection. Presumptive TB was defined as cough of any duration, fever, unexplained weight-loss, night-sweats or hemoptysis. Patients
with presumptive DM were defined as those aged over 30
years and with a family history of DM.
TB testing was carried out at purpose-built diagnostic
centers called Sehatmand Zindagi (Healthy Life) located in
Korangi and Nazimabad. The centers operate as a social
business that aim to provide sustainable TB care in the
private-sector. Revenue is generated through direct payment for tests by patients, including chest X-rays (USD 3–
5 per test), spirometry (USD 2.5–5 per test) and random
blood glucose testing (USD 0.3–0.5 per test). Xpert MTB/
RIF testing was provided free-of-cost to all patients following a chest X-ray. The centers served as the site of treatment initiation and case-registration to the Provincial TB
Program (PTP). The revenue generated is channeled into
subsidizing TB diagnosis and treatment.
Individuals with presumptive TB were referred by the
private health provider to the social business TB centers
for a paid chest X-ray, followed by a free Xpert MTB/
RIF test. Patients with bacteriologically positive TB were
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tested for DM through a glucometer-based random
blood sugar test (RBS) at the diagnostic centers. Individuals who came to the Centers with a previous diagnosis
of TB or DM were re-tested using Sehatmand Zindagi
Centers’ Chest X-ray, Xpert MTB/RIF and glucometerbased random blood sugar tests to ensure reliable baseline measures for diagnosis rather than depending on
external reports. 1180 individuals with known diabetes
(Table 1), defined as all those who self-reported to be
taking oral hypoglycemic medication, underwent glucometer based random blood sugar testing and then were
channeled into the presumptive DM-TB arm (Fig. 1).
Baseline data for previously diagnosed and newly diagnosed diabetes cases is indicated in Table 1. Previously diagnosed cases of diabetes were further classified as having
controlled or uncontrolled diabetes. For the purpose of
this analysis, uncontrolled diabetes was defined as RBS of

greater than 200 mg/dl on glucometer testing. Those with
presumptive DM were offered a paid (US $2),
point-of-care capillary blood-glucose test that was conducted by CHWs at the clinics. Cutoffs recommended by
the International Diabetes Federation for resource-limited
settings were used to categorize the patients as having
DM (≥200 mg/dL (11.1 mmol/L)), Pre-DM (140–199 mg/
dL (7.8–11.0 mmol/L)) or no diabetes (< 140 mg/dL (7.8
mmol/L)). Individuals with both presumptive TB and DM,
were assigned to another diagnostic arm where the private
health provider referred patients for both tests: a point of
care glucometer test for DM and Chest X-ray and Xpert
MTB/RIF testing at the diagnostic centers.
Data management and analysis

Data on DM and TB verbal screening results, referrals,
and DM test results was recorded using a custom-built

Table 1 Baseline characteristics of patients identified as pre-diabetics and diabetics through community-based screening
Characteristics

Cases diagnosed
with Pre-diabetes

Newly diagnosed
cases of Diabetes

Previously known cases of Diabetes
Uncontrolled

Total

Controlled

n

%

n

%

n

%

n

%

n

%

726

100

547

100

901

100

279

100

2453

100

Male

334

46

236

43.1

359

39.8

100

35.8

1029

41.9

Female

392

54

311

56.9

542

60.2

179

64.2

1424

58.1

< 30

74

10.2

29

5.3

28

3.1

28

10

159

6.5

30–39

195

26.9

98

17.9

129

14.3

51

18.3

473

19.2

Total Number of patients
Sex

Age

40–49

221

30.4

176

32.2

284

31.5

58

20.8

739

30.2

50–59

135

18.6

151

27.6

284

31.5

87

31.2

657

26.8

60–69

72

9.9

68

12.4

140

15.6

32

11.5

312

12.8

> 70

29

4.0

25

4.6

36

4.0

23

8.2

113

4.5

Yes

265

36.5

199

36.4

402

44.6

107

38.4

994

40.5

No

461

63.5

348

63.6

499

55.4

172

61.6

1459

59.5

Family History of Diabetes

Current or Previous Smoking History
Yes

88

12.1

55

10.1

32

3.6

37

13.3

212

8.6

No

638

87.9

492

89.9

869

96.4

242

86.7

2241

91.4

Sindhi

29

4.0

9

1.6

15

1.7

9

3.2

62

2.5

Balochi

09

1.2

5

0.9

8

0.9

4

1.4

26

1.1

Punjabi

21

2.9

18

3.3

25

2.8

20

7.2

84

3.4

Pathan

127

17.5

89

16.3

96

10.7

111

39.8

423

17.2

Muhajir

518

71.3

367

67.1

734

81.5

110

39.4

1729

70.5

Other

22

3.0

59

10.8

23

2.6

25

9.0

129

5.3

Yes

210

28.9

75

13.7

273

30.3

171

61.3

728

29.7

No

516

71.1

472

86.3

628

69.7

109

38.7

1725

70.3

Ethnicity

History of Hypertension
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Fig. 1 Diagnostic algorithm and results of TB-DM bidirectional screening Feb-Nov, 2014, Karachi, Pakistan

mobile-phone application. Other variables ascertained at
baseline included family-history of diabetes, smoking
history, ethnicity, and past history of TB treatment
(Table 2). Patients’ chest X-ray and Xpert MTB/RIF results at the diagnostic centers were recorded using
OpenMRS, an Open source enterprise electronic medical record system platform. The mobile and web applications included several data validation checks to ensure
data-accuracy. Field supervisors and project management staff were responsible for overall data-validation
and accuracy including reporting to the NTP.
Frequency analysis of baseline demographic characteristics of patients diagnosed with DM and Pre-DM/Impaired Fasting and TB were performed. The proportions
of individuals diagnosed with Pre-DM and DM that had
TB symptoms and subsequently underwent Xpert MTB/
RIF testing and diagnosed with TB were calculated. The
proportion of newly diagnosed DM cases among TB

patients was calculated. Differences between the DM
and Pre-DM groups were assessed for statistical significance using chi-square or Pearson’s test (Table 2). All
statistical analysis was carried out using Stata 12.1 (College Station, TX: StataCorp LP).
The primary study outcomes were uptake of TB testing and uptake of DM testing. Overall uptake of TB testing, overall uptake of DM testing, uptake of TB testing
and uptake of DM testing among patients presumptive
for both DM & TB were computed (Fig. 1). Additionally,
uptake of TB testing among pre-diabetic and diabetic
patients was assessed by comparing the proportion of
pre-diabetic and diabetic individuals that underwent
Chest X-ray and Xpert MTB/RIF testing to the proportion within each arm who were presumptive for TB. Uptake of DM testing among MTB positive patients was
computed by comparing the proportion of MTB positive
patients who underwent a glucometer-based random

Basir et al. BMC Health Services Research

(2019) 19:147

Page 5 of 9

Table 2 Baseline characteristics and results of glucometer testing conducted on TB patients through community-based TB-DM
screening

Total

Persons with TB Tested for DM*

Pre-Diabetes*

Newly Diagnosed DM cases

n

%

n

%

n

%

266

100

25

100

8

100

p-value†

Sex
Male

108

40.6

13

48.0

4

50.0

Female

158

59.4

12

48.0

4

50.0

< 20

60

22.6

4

16.0

0

0.0

20–29

93

35.0

5

20.0

0

0.0

30–39

43

16.2

2

8.0

1

12.5

40 and above

67

25.2

14

56.0

7

87.5

Yes

32

12.0

1

4.0

3

37.5

No

234

88.0

24

96.0

5

62.5

Yes

21

7.9

7

28.0

2

25.0

No

245

92.1

18

72.0

6

75.0

0.99

Age (years)
< 0.01

Family History of DM*
0.97

Current or Previous Smoking History
< 0.01

Ethnicity
Sindhi

14

5.3

2

8.0

2

25.0

Balochi

2

0.8

0

0.0

0

0.0

Punjabi

8

3.0

1

4.0

0

0.0

Pathan

118

44.4

5

20.0

3

37.5

Muhajir

91

34.2

12

48.0

1

12.5

Other

33

12.4

3

12.0

1

12.5

Negative (clinically diagnosed)

28

10.5

3

12.0

2

25.0

Very low-low

90

33.8

9

34.0

2

25.0

Medium

90

33.8

9

36.0

3

37.5

High

58

21.8

4

16.0

1

12.5

New

229

86.1

22

88.0

7

87.5

Retreatment

37

13.9

3

12.0

1

12.5

0.11

MTB Burden
0.85

Type of TB
0.75

*
The cut-offs for RBS testing were taken from the International Diabetes federation
† The p-value denotes the level of significance found when testing differences in sociodemographic characteristics between individuals identified as new DM
cases and those identified as pre-DM, among all TB patients who had a glucometer blood sugar test

blood sugar test to the proportion within that arm who
were presumptive for DM. The yield of TB among individuals identified with Pre-DM and DM was computed
as the proportion of individuals who tested positive for
TB among all individuals with DM and pre-DM who
underwent TB testing via chest X-ray and Xpert MTB/
RIF in this project. The yield of DM among individuals
diagnosed with TB was calculated as the proportion of
individuals identified with DM and Pre-DM among all
individuals with TB who underwent glucometer-based
RBS testing in this project.

Results
A total of 450,385 individuals were verbally screened
during the study period. Of those verbally screened,
3559 (0.8%) were identified as having presumptive DM,
14,550 (3.2%) with both presumptive DM and TB, and
75,587 (16.8%) as having presumptive TB only (Fig. 1).
The overall uptake of DM testing among those identified
with presumptive diabetes was 26.1% while the overall
uptake of TB testing among those with presumptive TB
was 5.9% (Fig. 1). Individuals with a presumptive diagnosis of both DM and TB were referred for both a
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glucometer based random blood sugar test and a Chest
X-ray and Xpert MTB/RIF test. Among the group that
was presumptive for both DM and TB, the uptake of
DM testing was 12.5% and the uptake of TB testing was
24.2% (Fig. 1).
Baseline socio-demographic and clinical characteristics of
pre-diabetic and diabetic patients

The majority of pre-diabetic and diabetic patients
self-identified as Muhajir (the most common ethnic
group in Karachi). Of those patients who tested positive
for diabetes, 547 (31.6%) were newly diagnosed. Of the
1180 previously known diabetes cases, 901 (76.4%) had
blood sugar levels above the recommended range for optimal diabetics control (Table 1). A higher proportion of
females were identified with pre-diabetes and diabetes
(58.1%) and a family history of diabetes, history of smoking and history of hypertension was reported in 40.5, 8.6
and 29.7% of diabetics respectively. A history of hypertension was reported in a higher proportion of previously known diabetics with controlled blood sugar levels
(61.3%) compared to known diabetics with poorly controlled blood sugar levels (30.3%), newly diagnosed diabetics (13.7%) and pre-diabetics (28.9%) (Table 1).
Baseline socio-demographic characteristics of TB patients

The yield of diabetes among TB patients was found to
be significantly higher in patients > 40 years of age
(p-value < 0.01) and among smokers compared to
non-smokers (p-value < 0.01) (Table 2). Gender, MTB
burden, ethnicity and past history of TB treatment were
not associated with an increased yield of DM (Table 2).
Uptake of diabetes testing

A total of 4722 (26.1%) individuals with presumptive
DM underwent glucometer testing, with 726 (15.4%)
identified as pre-diabetic (198 of whom had both presumptive TB and DM), and 1727 (36.6%) diagnosed with
diabetes (432 of whom had both presumptive DM and
TB). Among those diagnosed with TB, a higher proportion of those with presumptive DM consented for DM
screening using a glucometer, than those without presumptive DM (33.8% vs 14.7%, p < 0.001). Among those
who underwent glucometer testing, 25 (9.4%) were identified as pre-diabetics and 8 (3%) as diabetics. Of those
diagnosed with diabetes and pre-diabetes, 100 and 56%
(14/25) had presumptively screened positive for DM
(Fig. 1). The median age of individuals identified as presumptive for TB and DM was 34 years (IQR 25–45), and
47 years (IQR 38–55) respectively. The proportion of females among those identified as presumptive for TB and
DM, was 47.4 and 50.1% respectively.
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Uptake of TB testing

A high proportion (22.8%) of individuals with presumptive
TB, tested positive for MTB on Xpert MTB/RIF. Overall,
the uptake of screening for tuberculosis was quite low
among prediabetics and diabetics. 6.6% of prediabetic
cases and 3.9% of diabetic cases underwent TB testing via
Chest X-ray and Xpert MTB/RIF. However, the uptake
was significantly higher among those who had presumptive TB (22.2% vs 0.8% among pre-diabetics; and 13.7% vs
0.62% among diabetics). Of the 153 who consented for TB
testing, 153 had a chest X-ray and among these 115
(75.2%) underwent Xpert MTB/RIF testing (the remainder
were unable to expectorate sputum and excluded from
further diagnostic evaluation) (Table 3). A total of 8
pre-diabetics (16.7%) and 19 diabetics (28.4%) tested positive for TB on Xpert MTB/RIF testing (Fig. 1).

Discussion
Our study evaluated bi-directional TB-DM screening in
a high TB and DM prevalence setting. In this study, the
yield of TB among those with diabetes and pre-diabetes
was 23.5% while the yield of pre-DM/DM among individuals who had tested positive for TB was 12.4% (Fig.
1). However, it is important to note that the yield of TB
in our sample has a great risk of selection bias. Notably
all had presumptive TB; the number of diabetics without
presumptive TB who took up screening was too small to
comment on the yield of TB among those tested for TB
without any suggestive symptoms. A number of studies,
as well as the Pakistan TB prevalence survey have identified a large proportion of TB cases with only Chest
X-ray abnormalities and no TB symptoms supporting its
use as the front-line screening procedure [15]. Therefore, we aimed to test all individuals for TB using chest
radiography, regardless of symptoms. In circumstances
where chest X-rays are unavailable symptomatic screening can be used as an alternative. In this study, a high
yield of TB was recorded among those with TB symptoms. We were unable to assess the effectiveness of the
chest X-ray in identifying additional cases of TB as the
majority of cases referred were also symptomatic for TB.
While our study supports the growing body of literature highlighting the association between TB and DM
[8] it primarily identifies a number of operational constraints that programs may need to address during larger
scale TB-DM screening interventions. A high yield of
TB was found among the diabetics and pre-diabetics
within our study population. The uptake of diagnostic
evaluation for TB was low, and mainly confined to those
who had symptoms suggestive of TB. In addition, since
physician prescriptive practices also significantly affect
patient behavior, it is possible that only diabetics with
clinical suspicion of TB were actively referred [16]. Additional constraints in testing diabetics for TB included
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Table 3 Xpert MTB/RIF test results of individuals diagnosed with Diabetes and Pre-Diabetes through community-based screening

Total

Individuals identified with Pre-Diabetes

Individuals identified with Diabetes Mellitus

Total

Number(n)

Percent (%)

Number (n)

Percent (%)

Number (n)

Percent (%)

726

100

1727

100

2453

100

Underwent Paid Chest X-Ray

62

8.5

91

5.3

153

6.2

Underwent Xpert MTB/RIF

48

77.4

67

73.6

115

75.2

Diagnosed with TB

8

16.7

19

28.4

27

23.5

Started on treatment for TB

8

100

19

100

27

100

the price for the chest X-ray and the distance to the centers for diagnostic evaluation. Our experience suggests
that in a pay for testing model only diabetics with a high
suspicion of TB will be referred, as both providers and
patients perceived the costs and time associated with the
X-ray as key barriers. Also, approximately a quarter of
patients who agreed to undergo a chest X-ray, could not
be tested on Xpert MTB/RIF due to their inability to expectorate sputum and this further limited the number of
diabetics among whom the yield of TB could be assessed.
Our early experience of implementing TB-DM screening in a programmatic setting in the private-sector offers
a number of lessons for potential interventions that can
be carried out at scale. Firstly, physicians must be
trained to refer diabetics for routine screening for TB, as
is carried out for other diabetes-associated complications
such as nephropathy or retinopathy. Patients also need
to be appropriately counseled regarding the risks of developing TB, particularly those with poorly controlled
diabetes since they are at higher risk for developing TB
[17]. Secondly, user-fees for the X-ray and distance to
the TB centers limited the number of diabetics undergoing TB screening in our program. It can be assumed that
user fee is likely a barrier to uptake of preventive health
services such as screening for TB and DM. As a preventative intervention with potential public health benefits, cost-free or subsidized services may increase uptake
of TB testing. This may likely encourage pre-diabetics
and diabetics to undergo screening, particularly those
who have no symptoms of TB, and will help decrease
the case-detection gap for TB. Public health practitioners and program managers that are eager to roll out
a bi-directional TB-DM screening program in the private
sector, should incorporate greater cost subsidies for patients in the program budget. Third, scale-up of TB
screening in diabetics will require ensuring adequate
sputum expectoration from diabetics through use of
nebulizers and appropriate counseling. Commercial labs
in the private-sector and most healthcare providers do
not routinely carry out such procedures and will require
capacity-strengthening. Existing specialized diabetes
treatment centers with high volumes of known diabetics
or private-practices of diabetes and endocrine specialists
can be targeted to refer diabetics for TB screening.

Over 50% of diabetics and pre-diabetics identified in
our program were newly diagnosed further highlighting
the burden of undiagnosed diabetes and the need to
introduce affordable and accessible diabetes screening in
the private-sector at scale as a prelude for enhanced
case-detection for TB.
Screening for DM among TB patients presented fewer
operational challenges in our model as patients were offered screening during the time of registration for TB
treatment. The yield of pre-DM and DM identified
among individuals with TB in our program was higher
(12.4%) than the DM prevalence in the general population of Pakistan (6.9%) [8]. This is consistent with findings from similar studies from India that have reported a
prevalence between 5 and 54.1% of DM in TB patients
[18–20]. Routine screening for DM among TB patients
should therefore be considered at TB management facilities in Pakistan.
Diabetes screening for TB patients can be best carried
out at the time of initiation of TB treatment and registration. Low-cost, point-of-care tests for diabetes are recommended as patients are more likely to consent to them
although their results are less accurate. Interventions will
need to ensure that these tests are available either at laboratories or at provider clinics where TB treatment is initiated
for private-sector patients and data on diabetes screening
and control is captured as part of the TB surveillance system. Integrated delivery units such as the ones developed
by our project offer a potential solution where TB diagnostics, DM screening and TB-DM treatment can be offered
in one facility with supporting systems for data capture and
monitoring of outcomes.

Conclusion
This study provides evidence for the operationalization
and the associated challenges of bi-directional screening
of TB and DM in the private health sector of low-middle
income countries. A high yield for TB was identified
among diabetics and pre-diabetics in our study population, however the overall uptake of bi-directional screening remained low. A large number of diabetics were newly
identified suggesting the need for implementation of collateral active case-finding initiatives for DM. This study
also provides a potential model for integration of TB
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diagnostics, DM screening and TB-DM treatment within
one facility that can be similarly adapted for other areas of
public health. The private sector can be engaged
cost-effectively through trainings and incentives to help
achieve increased case-detection for both TB and DM.
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